NDC 81902-120 Centipaine For Pain Control

Lidocaine 4%, Menthol 1%

NDC Product Code 81902-120

NDC 81902-120-03

Package Description: 3 PATCH in 1 BOX > 4 g in 1 PATCH

NDC Product Information

Centipaine For Pain Control with NDC 81902-120 is a a human over the counter drug product labeled by Whitestone Products Llc. The generic name of Centipaine For Pain Control is lidocaine 4%, menthol 1%. The product's dosage form is patch and is administered via topical form. The RxNorm Crosswalk for this NDC code indicates a single RxCUI concept is associated to this product: 1373130.

Dosage Form: Patch - A drug delivery system that often contains an adhesive backing that is usually applied to an external site on the body. Its ingredients either passively diffuse from, or are actively transported from, some portion of the patch. Depending upon the patch, the ingredients are either delivered to the outer surface of the body or into the body. A patch is sometimes synonymous with the terms ‘extended release film’ and ‘system’.

Product Type: Human Otc Drug What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

Centipaine For Pain Control Active Ingredient(s)

What is the Active Ingredient(s) List?
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.


Inactive Ingredient(s)

About the Inactive Ingredient(s)
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product.

  • POLYACRYLAMIDE (10000 MW) (UNII: E2KR9C9V2I)
  • ETHENYL (UNII: PQ2K3G3591)
  • ACRYLATES CROSSPOLYMER-6 (UNII: 4GXD0Q3OS3)
  • SODIUM POLYACRYLATE (2500000 MW) (UNII: 05I15JNI2J)
  • WATER (UNII: 059QF0KO0R)

Administration Route(s)

What are the Administration Route(s)?
The translation of the route code submitted by the firm, indicating route of administration.

  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.

Product Labeler Information

What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.

Labeler Name: Whitestone Products Llc
Labeler Code: 81902
FDA Application Number: part348 What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

Marketing Category: OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final. What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Start Marketing Date: 12-23-2021 What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.

Listing Expiration Date: 12-31-2022 What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.

Exclude Flag: N - NO What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".

* Please review the disclaimer below.

Centipaine For Pain Control Product Label Images

Centipaine For Pain Control Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Product Labeling Index

Otc - Active Ingredient

Active IngredientsLidocaine 4%Menthol 1%

Otc - Purpose

PurposeTopical Analgesic

Indications & Usage

UsesFor the temporary relief of pain.

Warnings

WarningsFor external use only not intended for ingestion.

Otc - Do Not Use

  • Do not usein large quantities, particularly over raw surfaces, or blistered areas.

Otc - When Using

  • When using this productAvoid contact with the eyes.

Otc - Ask Doctor

  • Stop use and ask doctor ifcondition worsens, or if symtoms persist for more than 7 days or clear up and occur again within a few days.

Otc - Keep Out Of Reach Of Children

Keep out of reach of children.If swallowed, get medical help, or contact a Poison Control Central right away.

Otc - Pregnancy Or Breast Feeding

If pregnant or breast-feeding, ask a health professional before use.

Dosage & Administration

  • DirectionsAdults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times a daily. Children under 2 years of age: consult a doctor.

Other Safety Information

Other InformationStore at 20-25


oC (68-77


oF) and protect from moisture.

Inactive Ingredient

Inactive ingredientspolyacrylamide, vinol, sodium polyacrylate; acrylate polymerization, purified water.

Otc - Questions

Questions?(310) 320-0100

* Please review the disclaimer below.